The Nontreatment of Childhood ITP (or ``The Art of Medicine Consists of Amusing the Patient until Nature Cures the Disease'')

ABSTRACT

The management of childhood acute idiopathic thrombocytopenic purpura is controversial, with recent guidelines highlighting the lack of suitable evidence upon which to base management decisions. Three European centers have used an expectant policy and results over the past decade demonstrate that this is safe and convenient for the majority of children. Adequate parental education about the condition from an experienced specialist is essential, together with open access for children should they develop any problems. A clinical stratification of such patients must be incorporated into any future trials, together with quality of life assessment to discover the impact of restrictions on lifestyle, particularly in adolescents with chronic ITP who may need a different approach.

KEYWORD

Children - platelet count - expectant approach - drug toxicity - idiopathic thrombocytopenic purpura

REFERENCES

• 1 Hoyle C, Darbyshire P, Eden O B. Idiopathic thrombocytopenia in childhood. Edinburgh experience 1962-82.  Scott Med J . 1986;  31 174-179
• 2 Choi S I, McClure P D. Idiopathic thrombocytopenic purpura in childhood.  Can Med Assoc J . 1967;  97 562-568
• 3 Lusher J M, Zuelzer W W. Idiopathic thrombocytopenic purpura in childhood.  J Pediatr . 1966;  68 971-979
• 4 McElfresh A. Idiopathic thrombocytopenic purpura-to treat or not to treat?.  J Pediatr . 1975;  87 160-161
• 5 Buchanan G R. The nontreatment of childhood idiopathic thrombocytopenic purpura.  Eur J Pediatr . 1987;  146 107-112
• 6 Medeiros D, Buchanan G R. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood.  Pediatr Clin North Am . 1996;  43 757-772
• 7 Buchanan G R, de Alarcon A P, Feig S A. Acute idiopathic thrombocytopenic purpura-management in childhood [letter; comment].  Blood 1997. 89 1464-1465 (discussion 1466)
• 8 Bolton-Maggs P H, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines.  Lancet . 1997;  350 620-623
• 9 Bolton-Maggs P H. Acute idiopathic thrombocytopenic purpura-management in childhood [letter; comment].  Blood 1997. 89 1465 (discussion 1466)
• 10 Chessells J. Chronic idiopathic thrombocytopenic purpura: primum non nocere.  Arch Dis Child . 1989;  64 1326-1328
• 11 Cripe T P. Idiopathic thrombocytopenic purpura: reasons to resolve the chaos.  J Pediatr Hematol Oncol . 1999;  21 465-466
• 12 Imbach P, Barandun S, d'Apuzzo V. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.  Lancet . 1981;  1 1228-1231
• 13 Imbach P, Berchtold W, Hirt A. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.  Lancet . 1985;  2 464-468
• 14 Duhem C, Dicato M, Ries R. Side effects of intravenous immunoglobulins.  Clin Exp Immunol . 1994;  97 (Suppl 1) (79-83)
• 15 Kattamis A C, Shankar S, Cohen A R. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G.  J Pediatr . 1997;  130 281-283
• 16 Eden O B, Lilleyman J S. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.  Arch Dis Child . 1992;  67 1056-1058
• 17 Blanchette V, Imbach P, Andrew M. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.  Lancet . 1994;  344 703-707
• 18 Lilleyman J S. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology.  Arch Dis Child . 1994;  71 251-253
• 19 Lilleyman J S. Intracranial hemorrhage in chronic childhood ITP [editorial].  Pediatr Hematol Oncol . 1997;  14 iii-v
• 20 George J N, Woolf S H, Raskob G E. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.  Blood . 1996;  88 3-40
• 21 Zeller B, Glomstein A, Wesenberg F. Investigation and treatment of immune thrombocytopenic purpura in children in Norway.  Tidsskr Nor Laegeforen . 1996;  116 2157-2159
• 22 Sutor A, Dickerhoff R, Gaedicke G, Pollman H. Akute postinfectiöse Immunthrombozytopenie (ITP) im Kindesalter. In: Reinhardt E, ed. Leitlinien Kinderheilkunde und Jugendmedizin Munich: Urban and Fischer 1999: 23-27
• 23 Buchanan G R. Quantitative and qualitative platelet disorders.  Clin Lab Med . 1999;  19 71-86
• 24 Rowan R. Platelet counting and the assessment of platelet function. In: Koepke J, ed. Practical Laboratory Hematology New York: Churchill Livingstone 1991: 157-170
• 25 Dickerhoff R, von Rueker A. Enumeration of platelets by multiparameter flow cytometry using platelet-specific antibodies and fluorescent reference particles.  Clin Lab Haematol . 1995;  17 163-172
• 26 Sutor A H. Acute immune thrombocytopenia in childhood. Are we treating the platelet count?.  Semin Thromb Hemost . 1998;  24 545-548
• 27 Welch J, Vora A J. Expectant management of childhood immune thrombocytopenic purpura.  Int J Hematol . 2000;  72 (Suppl 1) (180-181)
• 28 Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulin or sustained prednisone treatment.  J Pediatr . 2000;  137 629-632
• 29 Bolton-Maggs P. The management of ITP-few need active therapy. An 8 year review of consecutive unselected cases.  Arch Dis Child . 2000;  G93 (Abst) (G93)
• 30 Tamminga R, Poortman G, Kamps W. Psychosocial impact of chronic idiopathic thrombocytopenic purpura: a parent's view.  Int J Pediatr Hematol Oncol . 1999;  6 255-260
• 31 Blanchette V S, Luke B, Andrew M. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.  J Pediatr . 1993;  123 989-995
• 32 Lilleyman J S. Management of childhood idiopathic thrombocytopenic purpura.  Br J Haematol . 1999;  105 871-875
• 33 Jayabose S, Mahmoud M, Levendoglu-Tugal O. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura.  J Pediatr Hematol Oncol . 1999;  21 514-517